A preprint released on December 25, 2021 analyzed the risk of myocarditis following multiple doses of the experimental COVID-19 injections. The study was conducted by UK researchers from institutions such as the University of Oxford, the University of Leicester, and the University of Edinburgh.
The researchers conducted a self-controlled case series analysis of over 42 million people age 13 or older. Their goal was to evaluate the association between COVID-19 inoculations and myocarditis. They categorized data by sex and age and included nearly 11 million people who received a third dose of the COVID-19 jabs.
The alarming results provide more evidence for regulators to halt these dangerous injections. The risk of myocarditis increased following multiple doses of the COVID-19 jabs, and the association was strongest in males under 40 years of age.
🚨 Risk of myocarditis following sequential COVID-19 vaccinations by age and sex
— Gerard Delaney (@Gerard39delaney) December 31, 2021
Unless I am misreading these data, second and third doses of vaccine should be ceased for healthy males under 40 immediately. @sarahknapton @UsforThemUK https://t.co/mvYcevIjWo
— Hugh Osmond (@hughosmond) December 30, 2021
It would seem that healthy males under 40 should not be recommended to have multiple vaccine doses. Risks for this group from multiple jabs higher than from Covid. @CMO_England https://t.co/mvYcevIjWo
— Hugh Osmond (@hughosmond) December 30, 2021
I’ve had chest pains since my second jab months ago. 4/5 ‘episodes’ a day. Absolutely no chance am I pumping anymore in 👍🏼
— Ash Stephenson (@ashtoon92) December 31, 2021
Estimated risk multiplier for myocarditis in men under 40 goes from 1.7 to 3.4 to 7.6 after 1st/2nd/3rd dose of Pfizer and from 2.3 to 16.5 after 1st/2nd dose of Moderna (vs 2.0 after a positive covid test). Anyone else concerned about direction of travel? https://t.co/YdHbxlSHPF
— James Doidge (@StraightStats) December 30, 2021
Oxford study shows the extreme elevated risk of myocarditis..normally any honest regulator should suspend it's usehttps://t.co/j7pUwRIGIB
— Dr Kevin Corbett MSc PhD (@KPCResearch) December 31, 2021
From "Risk of myocarditis following sequential COVID-19 vaccinations by age and sex":
"We observe an increase in myocarditis events following a 3rd dose of BNT162b vaccine. The incidence rate ratios are higher sequentially following each dose of mRNA vaccine." pic.twitter.com/vH75oeqsGT
— Overshoot (@Overshoooot) December 26, 2021
Could this be another indicator that explains why so many professional athletes are dropping on the playing surface to cardiac issues?
Read the Abstract from the preprint study titled “Risk of myocarditis following sequential COVID-19 vaccinations by age and sex”
In an updated self-controlled case series analysis of 42,200,614 people aged 13 years or more, we evaluate the association between COVID-19 vaccination and myocarditis, stratified by age and sex, including 10,978,507 people receiving a third vaccine dose. Myocarditis risk was increased during 1-28 days following a third dose of BNT162b2 (IRR 2.02, 95%CI 1.40, 2.91). Associations were strongest in males younger than 40 years for all vaccine types with an additional 3 (95%CI 1, 5) and 12 (95% CI 1,17) events per million estimated in the 1-28 days following a first dose of BNT162b2 and mRNA-1273, respectively; 14 (95%CI 8, 17), 12 (95%CI 1, 7) and 101 (95%CI 95, 104) additional events following a second dose of ChAdOx1, BNT162b2 and mRNA-1273, respectively; and 13 (95%CI 7, 15) additional events following a third dose of BNT162b2, compared with 7 (95%CI 2, 11) additional events following COVID-19 infection. An association between COVID-19 infection and myocarditis was observed in all ages for both sexes but was substantially higher in those older than 40 years. These findings have important implications for public health and vaccination policy.
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!